[go: up one dir, main page]

CN1299113C - Inspection for quality control of Longxuejie - Google Patents

Inspection for quality control of Longxuejie Download PDF

Info

Publication number
CN1299113C
CN1299113C CNB2005100108515A CN200510010851A CN1299113C CN 1299113 C CN1299113 C CN 1299113C CN B2005100108515 A CNB2005100108515 A CN B2005100108515A CN 200510010851 A CN200510010851 A CN 200510010851A CN 1299113 C CN1299113 C CN 1299113C
Authority
CN
China
Prior art keywords
dragon
blood
ascarin
solution
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2005100108515A
Other languages
Chinese (zh)
Other versions
CN1712953A (en
Inventor
陈植和
周家礽
汪伯良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Shengke Pharmaceutical Co ltd
Original Assignee
Kunming Dihon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Dihon Pharmaceutical Co Ltd filed Critical Kunming Dihon Pharmaceutical Co Ltd
Priority to CNB2005100108515A priority Critical patent/CN1299113C/en
Publication of CN1712953A publication Critical patent/CN1712953A/en
Application granted granted Critical
Publication of CN1299113C publication Critical patent/CN1299113C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

本发明涉及一种中药材原料药的检测方法,尤其是可以用以进行质量控制的成分的检测方法。发明所述的龙血竭质量控制检测方法是用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B含量的方法。本发明所述的龙血竭质量控制检测方法由以下步骤组成:一、色谱条件与系统适用性试验;二、对照品溶液的制备;三、供试品溶液的制备;四、测定。为了全面、准确地控制龙血竭的质量,本发明制定了用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B的含量。经分析方法验证,其精密度、重现性、回收率和稳定性符合中国药典2000年一部附录《中药质量标准分析方法验证指导原则》的要求。The invention relates to a method for detecting raw materials of Chinese medicinal materials, in particular to a method for detecting components that can be used for quality control. The quality control detection method of dragon blood jerky described in the invention is a method for simultaneously determining the contents of dragon blood jelly A and dragon blood jelly B by high performance liquid chromatography. The quality control detection method of Dracaena dracaena of the present invention consists of the following steps: 1. Chromatographic conditions and system applicability test; 2. Preparation of reference solution; 3. Preparation of test solution; 4. Determination. In order to comprehensively and accurately control the quality of dragon's blood, the present invention formulates a high-performance liquid chromatography method for simultaneously determining the contents of dragon's blood A and dragon's blood in dragon's blood. After the verification of the analytical method, its precision, reproducibility, recovery rate and stability meet the requirements of the Chinese Pharmacopoeia 2000, an appendix "Guiding Principles for the Validation of Analytical Methods of Quality Standards for Traditional Chinese Medicine".

Description

龙血竭质量控制检测方法Quality control detection method of dragon's blood

技术领域technical field

本发明涉及一种中药材原料药的检测方法,尤其是可以用以进行质量控制的成分的检测方法。The invention relates to a method for detecting raw materials of Chinese medicinal materials, in particular to a method for detecting components that can be used for quality control.

背景技术Background technique

龙血竭为龙舌兰科植物剑叶龙血树Dracaeua cochinchinensis(Lour.)S.H.Chen含脂木质部经提取加工成的树脂,为常用中药,有活血散瘀,定痛止血,敛疮生肌功效,主要用于跌打损伤,瘀血作痛,妇女气血凝滞,外伤出血,褥疮久不收口。已收载于国家药品标准WS3-082(Z-016)-99(Z)。目前所执行的标准质量控制只测定龙血素B(C18H20O5)的含量,经研究发现,龙血竭中主要成分为黄酮类,仅仅只控制药材中一种黄酮的量难以准确地反映产品质量。Dracaena cochinchinensis (Lour.) Dracaeua cochinchinensis (Lour.) SHChen, a plant of the family Agaveaceae, is a resin extracted and processed from the lipid-containing xylem. It is a commonly used traditional Chinese medicine. It is mainly used for bruises, blood stasis and pain, stagnation of Qi and blood in women, traumatic bleeding, and bedsores that persist for a long time. It has been included in the national drug standard WS3-082(Z-016)-99(Z). The currently implemented standard quality control only measures the content of dracaena B (C 18 H 20 O 5 ). It is found through research that the main components of dracaena japonicus are flavonoids, and it is difficult to accurately control the amount of only one type of flavonoid in the medicinal material. reflect product quality.

发明内容Contents of the invention

本发明的目的是提供一种全面、准确的控制龙血竭质量的龙血竭质量控制检测方法。The purpose of the present invention is to provide a comprehensive and accurate quality control detection method for dragon's blood to control the quality of dragon's blood.

本发明所述的龙血竭质量控制检测方法是用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B含量的方法。The quality control detection method of dragon's blood in the invention is a method for simultaneously measuring the contents of dragon's blood A and dragon's blood in dragon's blood by high-performance liquid chromatography.

为了全面、准确地控制龙血竭的质量,申请人对龙血竭中黄酮类成分进行了研究,提出增加其中含量高、易定量的龙血素A(C17H18O4)的含量测定,结果表明,云南产龙血竭中龙血素A含量较广西产的高5至6倍,且不同产地龙血竭中龙血素A含量差异较大,据文献报道龙血素A(C17H18O4)、龙血素B(C18H20O5)属黄酮类查耳酮类化合物,是龙血竭的主要有效成分。为确保产品质量可控和安全有效,申请人研究制定了用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B的含量。经分析方法验证,其精密度、重现性、回收率和稳定性符合中国药典2000年一部附录《中药质量标准分析方法验证指导原则》的要求。In order to comprehensively and accurately control the quality of dragon's blood, the applicant has conducted research on flavonoids in dragon's blood, and proposed to increase the content of dragon's blood A (C 17 H 18 O 4 ), which is high in content and easy to quantify. , the results showed that the content of dracaine A in Dracaena dracaena produced in Yunnan was 5 to 6 times higher than that produced in Guangxi, and the content of dracaena in Dracaena dracaena from different origins was quite different. 17 H 18 O 4 ) and dragon's blood B (C 18 H 20 O 5 ) belong to the flavonoid chalcone compounds, and are the main active ingredients of dragon's blood. In order to ensure that the product quality is controllable, safe and effective, the applicant has researched and developed a high-performance liquid chromatography method for the simultaneous determination of the contents of dracaine A and dracaine B in dragon's blood. After the verification of the analytical method, its precision, reproducibility, recovery rate and stability meet the requirements of the Chinese Pharmacopoeia 2000, an appendix "Guiding Principles for the Validation of Analytical Methods of Quality Standards for Traditional Chinese Medicine".

本发明所述的龙血竭质量控制检测方法由以下步骤组成:Dragon's blood quality control detection method of the present invention is made up of the following steps:

一、色谱条件与系统适用性试验1. Chromatographic conditions and system suitability test

用十八烷基硅烷键合硅胶为填充剂;冰醋酸溶液1→100-乙腈63±1∶37±1为流动相,检测波长为275±2nm,柱温:30±1℃,理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0;Octadecylsilane bonded silica gel is used as filler; glacial acetic acid solution 1→100-acetonitrile 63±1∶37±1 is used as mobile phase, detection wavelength is 275±2nm, column temperature: 30±1℃, number of theoretical plates According to the calculation of dragon blood A and B peaks, it should not be less than 5000, and the separation degree of dragon blood A and B peaks should be greater than 2.0;

二、对照品溶液的制备Two, the preparation of reference substance solution

称取经干燥剂减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B 0.04mg的混合溶液,即得;Weigh an appropriate amount of ascarin A and ascarin B reference substances dried under reduced pressure by a desiccant for 24 hours, add methanol to dissolve and make a mixed solution containing 0.18 mg of ascarin A and 0.04 mg of ascarin B per 1 ml, instant;

三、供试品溶液的制备Three, the preparation of test solution

取本品粉末约0.25g,精密称定至25ml量瓶中,加入甲醇约20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得;Take about 0.25g of the powder of this product, accurately weigh it into a 25ml measuring bottle, add about 20ml of methanol, sonicate for 10 minutes to dissolve the dragon's blood, let it cool to room temperature, dilute to the mark with methanol, shake well, 0.45μm micropore Filtrate through a filter membrane, discard the initial filtrate, and obtain;

四、测定4. Determination

精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and obtain it.

本发明的方法学考察:Methodological investigation of the present invention:

线性关系考察:Linear relationship investigation:

分别精密吸取对照品溶液1、2、5、10、15、20ul,按上述色谱条件测定峰面积,结果见表1,采用Agilent色谱工作站Chem Station计算标准曲线,见图1、图2。以峰面积积分值对样量进行回归,龙血素A在0.1840μg---3.680μg、龙血素B在0.0419μg---0.8380μg范围内显现良好的线性关系。龙血素A回归方程为:Y=3411.92X+34.40,r=0.99989;龙血素B回归方程为:Y=2694.85X+14.79,r=0.99960;其中Y为峰面积,X为进样量,r为相关系数。Accurately draw 1, 2, 5, 10, 15, and 20 ul of the reference solution respectively, and measure the peak area according to the above-mentioned chromatographic conditions. The sample volume was regressed by the peak area integral value, and a good linear relationship was shown in the range of 0.1840 μg---3.680 μg for ascarin A and 0.0419 μg---0.8380 μg for ascarin B. The regression equation of dragon blood A is: Y=3411.92X+34.40, r=0.99989; the regression equation of dragon blood B is: Y=2694.85X+14.79, r=0.99960; where Y is the peak area, X is the injection volume, r is the correlation coefficient.

                      表1线性关系考察结果   进样量(μl)          龙血素A           龙血素B  进样量(μg)   峰面积  进样量(μg)   峰面积   125101520  0.18400.36800.92001.8402.7603.680   634.91269.53179.96468.99433.612527.0  0.04190.08380.20950.41900.62850.8380   119.0235.2588.11195.91690.12259.7 Table 1 Linear relationship inspection results Injection volume (μl) Dragon blood A Dragon blood B Injection amount (μg) Peak area Injection amount (μg) Peak area 125101520 0.18400.36800.92001.8402.7603.680 634.91269.53179.96468.99433.612527.0 0.04190.08380.20950.41900.62850.8380 119.0235.2588.11195.91690.12259.7

精密度试验:Precision test:

取同一龙血素A及龙血素B对照品溶液,按上述色谱条件,连续测定6次(进样10μl),测得峰面积积分值见表2。Take the same reference substance solution of dragon blood A and dragon blood B, according to the above-mentioned chromatographic conditions, measure continuously 6 times (injection 10 μ l), the measured peak area integral value is shown in Table 2.

         表2精密度试验结果   次数   龙血素A峰面积   龙血素B峰面积   123456平均值RSD(%)   6389.56351.96363.36364.96361.06361.16365.30.20   1116.01112.11115.81118.01119.31116.91116.40.22 Table 2 precision test results frequency Dragon blood A peak area Dragon blood B peak area 123456 mean RSD(%) 6389.56351.96363.36364.96361.06361.16365.30.20 1116.01112.11115.81118.01119.31116.91116.40.22

稳定性试验:Stability test:

取同一供试品溶液,按上述色谱条件,进样10μl,在不同时间测定,结果见表3。Take the same test solution, according to the above chromatographic conditions, inject 10 μl of sample, and measure at different times, the results are shown in Table 3.

        表3稳定性试验结果   时间   龙血素A   龙血素B   05hr25hr45hr96hr166hr平均值RSD   10525.510510.610645.610684.210544.010738.410608.050.89%   1620.31627.81644.81652.21663.21678.21647.751.31% Table 3 Stability test results time Dragon blood A Dragon blood B 05hr25hr45hr96hr166hr average RSD 10525.510510.610645.610684.210544.010738.410608.050.89% 1620.31627.81644.81652.21663.21678.21647.751.31%

结果表明,样品在166hr(约7天)内比较稳定。The results showed that the sample was relatively stable within 166hr (about 7 days).

重现性试验:Reproducibility test:

取龙血竭粉末(过三号筛,小试样)约0.25g,共称取6份,按含量测定方法试验,结果见表4。Take about 0.25 g of dragon's blood powder (passed through No. 3 sieve, small sample), weigh 6 parts in total, and test according to the content determination method. The results are shown in Table 4.

          表4重现性试验结果   编号   取样量(g)   龙血素A(%)  龙血素B(%)   123456   0.25820.24570.24640.26550.24880.2310   2.882.892.852.922.932.84  0.580.580.580.590.590.59   含量平均值   2.885  0.585   RSD   1.2  0.94 Table 4 Reproducibility test results serial number Sampling amount (g) Dragon blood A (%) Dragon blood B (%) 123456 0.25820.24570.24640.26550.24880.2310 2.882.892.852.922.932.84 0.580.580.580.590.590.59 Average content 2.885 0.585 RSD 1.2 0.94

结果表明,重现性良好。The results showed good reproducibility.

加样回收率试验:Sample recovery test:

取已测定含量龙血竭粉末(中试样品,010101;含龙血素A为2.80%、龙血素B为0.59%)约0.12g,共称取6份,精密称定,置25ml量瓶中,精密加入龙血素A及B对照品溶液(每1ml中含龙血素A 0.1840mg/ml、龙血素B 0.0419mg/ml)10、15、20ml,补加甲醇至约20ml,超声处理10min,放至室温,加入甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,取续滤液,测定含量并计算回收率,结果见表5、表6。Take about 0.12g of dragon’s blood jerky powder (pilot test sample, 010101; containing 2.80% asdracaine A and 0.59% asdracaine B) whose content has been determined, weigh 6 parts in total, weigh them accurately, and put them in 25ml volume In the bottle, add 10, 15, 20ml of dragon blood A and B reference solution (each 1ml contains dragon blood A 0.1840mg/ml, dragon blood B 0.0419mg/ml), add methanol to about 20ml, Sonicate for 10 minutes, let it cool to room temperature, add methanol to dilute to the mark, shake well, filter through a 0.45 μm microporous membrane, take the subsequent filtrate, measure the content and calculate the recovery rate, the results are shown in Table 5 and Table 6.

                   表5龙血素A加样回收率试验结果 编号 取样量  样品龙血素A含量 加样量 测得总量 回收率   123456   0.1166g0.1138g0.1216g0.1131g0.1208g0.1291g  3.26mg3.19mg3.40mg3.17mg3.38mg3.61mg   1.84mg1.84mg2.76mg2.76mg3.68mg3.68mg   5.06mg4.95mg6.04mg5.93mg6.94mg7.18mg   97.8%95.7%95.7%100.0%96.7%97.0% Table 5 Dragon blood A sample addition recovery rate test result serial number Sampling volume Sample dragon blood A content Sample volume Measured total Recovery rate 123456 0.1166g0.1138g0.1216g0.1131g0.1208g0.1291g 3.26mg3.19mg3.40mg3.17mg3.38mg3.61mg 1.84mg1.84mg2.76mg2.76mg3.68mg3.68mg 5.06mg4.95mg6.04mg5.93mg6.94mg7.18mg 97.8% 95.7% 95.7% 100.0% 96.7% 97.0%

                  表6龙血素B加样回收率试验结果 编号 取样量  样品龙血素B含量 加样量 测得总量 回收率   123456   0.1166g0.1138g0.1216g0.1131g0.1208g0.1291g  0.69mg0.67mg0.72mg0.67mg0.71mg0.76mg   0.419mg0.419mg0.629mg0.629mg0.838mg0.838mg   1.09mg1.08mg1.32mg1.30mg1.53mg1.59mg   95.5%97.9%95.4%100.2%97.9%99.0% Table 6 Dragon's blood B addition recovery rate test result serial number Sampling volume Sample dragon blood B content Sample volume Measured total Recovery rate 123456 0.1166g0.1138g0.1216g0.1131g0.1208g0.1291g 0.69mg0.67mg0.72mg0.67mg0.71mg0.76mg 0.419mg0.419mg0.629mg0.629mg0.838mg0.838mg 1.09mg1.08mg1.32mg1.30mg1.53mg1.59mg 95.5% 97.9% 95.4% 100.2% 97.9% 99.0%

结果表明,本品加样回收率符合规定。The results show that the sample recovery rate of this product meets the requirements.

附图说明Description of drawings

图1为龙血素A标准曲线图。Figure 1 is a standard curve diagram of dragon blood A.

图2为龙血素B标准曲线图。Figure 2 is a standard curve diagram of dragon blood B.

具体实施方式Detailed ways

实施例:Example:

色谱条件与系统适用性试验 用十八烷基硅烷键合硅胶为填充剂;冰醋酸溶液(1→100)-乙腈(63∶37)为流动相,检测波长为275nm。柱温:30℃。理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0。Chromatographic conditions and system suitability test Octadecylsilane bonded silica gel was used as filler; glacial acetic acid solution (1→100)-acetonitrile (63:37) was used as mobile phase, and the detection wavelength was 275nm. Column temperature: 30°C. The number of theoretical plates should not be less than 5,000 based on the calculation of the peaks A and B of dragon blood, and the separation degree between peak A and peak B of dragon blood should be greater than 2.0.

对照品溶液的制备 精密称取经五氧化二磷减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B0.04mg的混合溶液,即得。Preparation of Reference Substance Solution Accurately weigh the appropriate amount of reference substances of dragon blood A and dragon blood B which have been dried under reduced pressure by phosphorus pentoxide for 24 hours, add methanol to dissolve and make each 1ml containing dragon blood A 0.18mg, containing dragon blood A mixed solution of 0.04 mg of element B is obtained.

供试品溶液的制备 取本品粉末(过三号筛)约0.25g,精密称定至25ml量瓶中,加入甲醇约20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得。Preparation of the test solution Take about 0.25g of the powder of this product (passed through a No. 3 sieve), accurately weigh it into a 25ml measuring bottle, add about 20ml of methanol, and sonicate for 10 minutes to dissolve the dragon’s blood, let it cool to room temperature, and use Dilute with methanol to the mark, shake well, filter through a 0.45 μm microporous membrane, discard the initial filtrate, and obtain the product.

测定法 精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。Determination method Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and obtain it.

Claims (2)

1、一种龙血竭质量控制检测方法,是用高效液相色谱法同时测定龙血竭中龙血素A和龙血素B含量的方法,其特征在于由以下步骤组成:1, a kind of dragon's blood quality control detection method, is the method for simultaneously measuring dragon's blood A and dragon's blood B content in dragon's blood by high performance liquid chromatography, is characterized in that being made up of following steps: 一、色谱条件与系统适用性试验  用十八烷基硅烷键合硅胶为填充剂;1%冰醋酸水溶液-乙腈63±1∶37±1为流动相,检测波长为275±2nm,柱温:30±1℃,理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0;1. Chromatographic conditions and system suitability test Use octadecylsilane bonded silica gel as filler; 1% glacial acetic acid aqueous solution-acetonitrile 63±1:37±1 as mobile phase, detection wavelength is 275±2nm, column temperature: 30±1°C, the number of theoretical plates should be no less than 5000 based on the calculation of the peaks of draconin A and B, and the separation degree of the peaks of dracaine A and B should be greater than 2.0; 二、对照品溶液的制备  称取经干燥剂减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B0.04mg的混合溶液,即得;2. Preparation of reference substance solution Weigh appropriate amount of reference substances of ascarin A and ascarin B that have been dried under reduced pressure in a desiccant for 24 hours, add methanol to dissolve and make 0.18 mg of ascarin A and 0.18 mg of ascarinin per 1 ml The mixed solution of B0.04mg is ready; 三、供试品溶液的制备  取本品粉末0.25g,精密称定至25ml量瓶中,加入甲醇20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得;3. Preparation of the test solution Take 0.25g of the powder of this product, accurately weigh it into a 25ml measuring bottle, add 20ml of methanol, and sonicate for 10 minutes to dissolve the dragon’s blood, let it cool to room temperature, dilute to the mark with methanol, shake Evenly, filter through a 0.45 μm microporous membrane, discard the initial filtrate, and obtain; 四、测定  精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。4. Determination Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and get it. 2、按照权利要求1所述的龙血竭质量控制检测方法,其特征在于由以下步骤组成:2. The method for detecting the quality of dragon's blood according to claim 1, characterized in that it consists of the following steps: 一、色谱条件与系统适用性试验  用十八烷基硅烷键合硅胶为填充剂;1%冰醋酸水溶液-乙腈63∶37为流动相,检测波长为275nm,柱温:30℃,理论板数按龙血素A及B峰计算均应不低于5000,龙血素A峰与B峰分离度应大于2.0;1. Chromatographic conditions and system suitability test Use octadecylsilane bonded silica gel as filler; 1% glacial acetic acid aqueous solution-acetonitrile 63:37 as mobile phase, detection wavelength is 275nm, column temperature: 30°C, number of theoretical plates According to the calculation of dragon blood A and B peaks, it should not be less than 5000, and the separation degree of dragon blood A and B peaks should be greater than 2.0; 二、对照品溶液的制备  精密称取经五氧化二磷减压干燥24小时的龙血素A、龙血素B对照品适量,加甲醇溶解并制成每1ml含龙血素A 0.18mg、含龙血素B 0.04mg的混合溶液,即得;2. Preparation of reference substance solution Accurately weigh the appropriate amount of reference substances of ascarin A and ascarin B that have been dried under reduced pressure by phosphorus pentoxide for 24 hours, add methanol to dissolve and make each 1ml containing ascarin A 0.18mg, containing The mixed solution of dragon blood B 0.04mg is ready; 三、供试品溶液的制备  取过三号筛的本品粉末0.25g,精密称定至25ml量瓶中,加入甲醇20ml,超声处理10分钟使龙血竭溶解,放冷至室温,用甲醇稀释至刻度,摇匀,0.45μm微孔滤膜滤过,弃去初滤液,即得;3. Preparation of the test solution Take 0.25g of the powder of this product passed through the No. 3 sieve, accurately weigh it into a 25ml measuring bottle, add 20ml of methanol, and sonicate for 10 minutes to dissolve the dragon's blood, let it cool to room temperature, and dissolve it with methanol Dilute to the mark, shake well, filter through a 0.45 μm microporous membrane, discard the initial filtrate, and obtain; 四、测定法  精密吸取对照品溶液10μl与供试品溶液5μl,注入液相色谱仪,测定,即得。4. Determination method Precisely draw 10 μl of the reference substance solution and 5 μl of the test solution, inject it into the liquid chromatograph, measure it, and get it.
CNB2005100108515A 2005-06-13 2005-06-13 Inspection for quality control of Longxuejie Expired - Lifetime CN1299113C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100108515A CN1299113C (en) 2005-06-13 2005-06-13 Inspection for quality control of Longxuejie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100108515A CN1299113C (en) 2005-06-13 2005-06-13 Inspection for quality control of Longxuejie

Publications (2)

Publication Number Publication Date
CN1712953A CN1712953A (en) 2005-12-28
CN1299113C true CN1299113C (en) 2007-02-07

Family

ID=35718656

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100108515A Expired - Lifetime CN1299113C (en) 2005-06-13 2005-06-13 Inspection for quality control of Longxuejie

Country Status (1)

Country Link
CN (1) CN1299113C (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101780191B (en) * 2009-01-20 2013-09-04 江苏康缘药业股份有限公司 Method for controlling quality of Resina Draconis-drug extract
CN101780189B (en) * 2009-01-20 2013-03-20 江苏康缘药业股份有限公司 Method for detecting Resina Draconis drug
CN101780190B (en) * 2009-01-20 2013-05-01 江苏康缘药业股份有限公司 Detection method for pharmaceutic preparation containing sanguis draconis extract
CN102081074B (en) * 2009-11-30 2013-09-11 昆明制药集团股份有限公司 Quality detection method for 2'-hydroxy-4,4',5',6'-tetramethyl-tetramethoxide chalcone
CN102359996A (en) * 2011-05-13 2012-02-22 云南大唐汉方制药有限公司 Quality detection method for dranaena cochinchinensis
CN102885801B (en) * 2012-09-28 2014-12-17 中国人民解放军第四军医大学 Application of Chinese medicinal monomer compound extracted from dragon's blood
CN103760219B (en) * 2014-01-16 2016-04-06 江苏康缘药业股份有限公司 A kind of method based on multiple liposoluble ingredient in DART/Q-TOF method Analysis and Identification Resina Draconis
CN106950304B (en) * 2017-03-23 2019-10-29 北京中医药大学 The quality determining method of Resina Draconis phenols extract and its preparation
CN112684093B (en) * 2020-12-08 2022-11-25 广西中医药大学 A quality detection method for eleven prescription medicinal wine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157197A1 (en) * 1998-10-27 2003-08-21 Okunji Christopher O. Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
CN1481788A (en) * 2002-09-12 2004-03-17 江苏康缘药业股份有限公司 A preparation method and quality control method of dragon's blood jerky total flavonoids preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157197A1 (en) * 1998-10-27 2003-08-21 Okunji Christopher O. Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
CN1481788A (en) * 2002-09-12 2004-03-17 江苏康缘药业股份有限公司 A preparation method and quality control method of dragon's blood jerky total flavonoids preparation

Also Published As

Publication number Publication date
CN1712953A (en) 2005-12-28

Similar Documents

Publication Publication Date Title
CN108760903B (en) Fingerprint spectrum determination method for Shuanghuanglian oral preparation
CN1299113C (en) Inspection for quality control of Longxuejie
CN106770828B (en) A kind of method for simultaneous determination of multicomponent content in Ginkgo biloba extract and its preparation
CN101647829B (en) A kind of high performance liquid chromatography detection method of ginkgolide injection
CN115980202B (en) HPLC Detection Method for Related Substances in Bromhexine Hydrochloride API
CN107860832A (en) The method for building up of compound rubarb Qi Yi Tang finger-print
CN107064322B (en) HPLC Wavelength Switching Method for Simultaneous Determination of Gallic Acid and Burnet Saponin I in Burnet or Burnet Preparations
CN103822975B (en) A kind of detection method of formulation of ' Sheng Mai ' of Radix Codonopsis side
CN104807896A (en) Identification and content determination method of traditional Chinese medicine gelata
CN108896681B (en) Nerve-soothing brain-tonifying liquid multi-index quantitative fingerprint establishment method and application thereof
CN109655558B (en) A kind of detection method of effective parts group of black bone vine
CN107389821A (en) A kind of method of active ingredient in measure ageratum oral liquid
CN102735772A (en) Quality controlling method of ganoderma aqueous extract
CN111796047B (en) Method for establishing fingerprint characteristic spectrum of Reyanning preparation and application thereof
CN1790013A (en) Method for simultaneous determination of protocatechuic acid content and 5-hydroxymethyl furfural content in pulse-activating injection
CN111089930B (en) A method for constructing UPLC characteristic map of Xinyi formula granules and its component content determination
CN111323508B (en) Method for determining content of 2, 4-dihydroxy-6-methoxyacetophenone in blumea balsamifera oil
CN116381088A (en) A method and application of multi-component content determination based on HPLC dual-wavelength gradient elution
CN104267114A (en) Detection method of nymphaea candida presl
CN1515904A (en) A kind of gastrodin content assay method
CN116559302A (en) Application of wall grass alkali in kadsura pepper stem sample quality detection and corresponding quality detection method
CN113917039A (en) Method for measuring content of effective components in pepper and products thereof
CN115993415B (en) A new method for detecting polymer content in cefcapone hydrochloride
CN102379934A (en) High efficiency liquid chromatography detection method for content of raddeanin A in rhizoma anemones raddeanae
CN113533598B (en) High performance liquid chromatography analysis method for content of scutellaria baicalensis in infantile lung heat cough and asthma granules

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: SHANGHAI DIHON MEDICAL CO.,LTD.

Assignor: KUNMING DIHON PHARMACEUTICAL Ltd.

Contract fulfillment period: 2009.10.25 to 2017.10.25

Contract record no.: 2009530000048

Denomination of invention: Inspection for quality control of Longxuejie

Granted publication date: 20070207

License type: Common License

Record date: 20091202

LIC Patent licence contract for exploitation submitted for record

Free format text: COMMON LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.10.25 TO 2017.10.25; CHANGE OF CONTRACT

Name of requester: SHANGHAI DIHON PHARMACEUTICAL CO., LTD.

Effective date: 20091202

C56 Change in the name or address of the patentee

Owner name: DIHON PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: KUNING DIANHONG PHARMACEUTICAL CO., LTD.

CP03 Change of name, title or address

Address after: 650106 Kunming science and Technology Development Zone, Yunnan Province Road No. 45

Patentee after: DIHON PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 650106 No. 45, medical Road, Kunming hi tech Industrial Development Zone, Yunnan, Kunming

Patentee before: KUNMING DIHON PHARMACEUTICAL Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20191225

Address after: 650503 1298 Bio Valley Street, majinpu, Kunming, Yunnan

Patentee after: Yunnan Shengke Pharmaceutical Co.,Ltd.

Address before: 650106 No. 45, medical Road, hi tech Development Zone, Yunnan, Kunming

Patentee before: DIHON PHARMACEUTICAL GROUP Co.,Ltd.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20070207